NIDCR Prospective Observational or Biomarker Validation Study Cooperative Agreement (U01 Clinical Trial Not Allowed)
National Institutes of Health
Free. Verify your email, then we send one reminder only.
- Posted
- Oct 23, 2025
- Amount
- $500,000
- Closes
- Jul 5, 2029 (in 1059 days)
Similar opportunities open now
- NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)OpenNational Institutes of HealthCloses Jul 2029
- NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed)OpenNational Institutes of HealthCloses May 2029
- Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed)OpenNational Institutes of HealthCloses in 64 days
- NIH Collaborative International Research Project (Parent PF5 Clinical Trial Optional)OpenNational Institutes of HealthCloses May 2029
- NIDCR Drug, Biologic, Device and/or Procedure Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)OpenNational Institutes of HealthCloses Jan 2028
Classification and identifiers
- Solicitation number
- PAR-27-058
- Assistance listing (CFDA)
- 93.121
Amount
$500,000
Who can apply
Local government agencies and Public colleges and universities can all apply here. Check the eligibility details below to see if your organization fits.
Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International CollaborationsNon-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
About this opportunity
This Notice of Funding Opportunity (NOFO) will support, through the cooperative agreement mechanism, investigator-initiated observational studies or biomarker validation studies that require prospective collection of data/biospecimens or continued analysis of data/biospecimens.
Related opportunities
- NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)National Institutes of HealthCloses Jul 2029
- NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed)National Institutes of HealthCloses May 2029
- Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed)National Institutes of HealthCloses in 64 days
- NIH Collaborative International Research Project (Parent PF5 Clinical Trial Optional)National Institutes of HealthCloses May 2029
- NIDCR Drug, Biologic, Device and/or Procedure Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)National Institutes of HealthCloses Jan 2028
- NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed)National Institutes of HealthCloses May 2029